Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Nursery places for three-year-olds: introduction of free entitlement did not deliver long-term benefits for children?s development, new research finds

  • Boosting use of multi-sensory environments in dementia care

  • Clot dissolver tpa's tardy twin could aid in stroke recovery

  • Exposure therapy appears helpful in treating patients with prolonged grief

  • Omega 3 can help children with ADD, experts say

  • Music therapy reduces depression in children, adolescents

  • Teens whose parents exert more psychological control have trouble with closeness, independence

  • Two days later: Adolescents' conflicts with family spill over to school, vice versa

  • If you're over 60, drink up: Alcohol associated with better memory

  • A new tune: There is intonation in sign language too

  •